menu
    • menu

    Company profile for Ipca Laboratories

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is ded...
    Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ipca Laboratoriesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Kandivli (West), Mumbai – 400 067, Maharashtra
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ipca.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ipca/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4587

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    The contract development and manufacturing organization (CDMO) space continued to grow at an impressive pace in the second half (H2) of 2024, with significant progress being made across cell and gene therapies (CGTs), antibody-drug conjugates (ADCs), novel drug modalities, and digital solutions.Some of the key players in the CDMO space include Lonza, EUROAPI, Evonik, SEQENS, Fujifilm Diosynth Biotechnologies, Quotient Sciences, Axplora, PolPharma, and Famar from Europe; Mission CDMO, LGM Pharma, Veranova, and Thermo Fisher from the US; and Samsung Biologics, Bora Pharmaceuticals, and Porton Pharma Solutions from Asia. Texas-based Mission CDMO has been in the pharma industry for over 75 years. Today, it is known for its comprehensive contract services and high-quality manufacturing capabilities that have reinforced its position as a trusted partner. View CDMO Activity Tracker for H2 2024 (Free Excel Available)Bora, PolPharma drive CDMO acquisitions; Samsung Biologics clocks over US$ 4 bn in contract valueThe second half of 2024 saw several high-value acquisitions and expansions that reshaped the CDMO landscape. South Korea-based Samsung Biologics clocked a cumulative contract value of over US$ 4 billion. It signed its largest manufacturing deal with an Asia-based pharmaceutical company, valued at US$ 1.24 billion. It also announced a series of manufacturing deals with a European drugmaker worth over US$ 668 million. Samsung Biologics is also building a dedicated ADC facility that is likely to be complete soon. Taiwan’s largest CDMO, Bora Pharmaceuticals, announced its second acquisition of the year. It bought New Jersey-based Pyros Pharmaceuticals, a developer of rare disease treatments. Pyros recently launched Vigafyde, the only ready-to-use vigabatrin oral solution and the first new product approved to treat infantile spasms in 15 years. Bora also announced a strategic investment in Tanvex Biopharma, thereby creating a global platform for biologics development and supply.PolPharma acquired Ziołolek, a renowned manufacturer of dermatological products, medical devices, and OTC medicines, thereby expanding its product portfolio. It also launched a state-of-the-art HPAPI (highly potent active pharmaceutical ingredients) facility in Poland, which is being seen as another step towards securing Europe’s drug supply chain.In other developments, Avid Bioservices got acquired by funds managed by Ampersand and British healthcare investment firm GHO Capital Partners in an all-cash deal worth US$ 1.1 billion. And Agilent Technologies agreed to acquire Canadian specialty CDMO Biovectra for US$ 925 million, thereby enhancing its capabilities in gene-editing technologies and sterile fill-finish services. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Evonik, EUROAPI, Porton Pharma, GSK announce tieups, technological expansionsSeveral CDMOs announced new collaborations and acquired new capabilities to enhance their service offerings. Evonik expanded its formulation capabilities for lipid nanoparticles used for mRNA and gene therapies through a collaboration with KNAUER Wissenschaftliche Geräte. This partnership aims to expand Evonik’s portfolio of biosolutions.Evonik is also restructuring its keto and pharma amino acid business to focus on strategic core growth areas. Evonik launched Eudracap colon functional capsules for targeted delivery of oral drugs. These ready-to-fill capsules are designed to release their contents specifically in the colon, improving the efficacy of treatments for various gastrointestinal conditions. Evonik also opened a new facility for drying aqueous dispersions of Eudragit polymers in Darmstadt, Germany. This facility will enhance Evonik’s capabilities in producing high-quality polymers for pharmaceutical applications.EUROAPI launched a new AI-powered Electronic Batch Record solution in collaboration with Aizon to enhance manufacturing productivity. This collaboration aims to digitize operations towards more data-driven manufacturing, focusing on small-scale productions and highly flexible plants.Porton Pharma Solutions has expanded its reach through several strategic initiatives. In October, Porton entered into a partnership with Shanghai InnoStar to enhance its service offerings beyond small molecules, targeting peptides, oligonucleotide drugs, conjugated drugs, and advanced therapies. It continued to grow its capabilities by enhancing its GMP manufacturing capacity in Fengxian, Shanghai (China). The facility’s expansion is aimed at increasing the production of novel therapies, including peptides and oligonucleotide drugs. These moves are part of Porton’s broader strategy to position itself at the forefront of advanced pharmaceutical manufacturing.Corden Pharma is investing € 900 million (US$ 985 million) over the next three years to expand its peptide platform facilities in Colorado (US) and Europe. While the US site will help meet the rising demand for GLP-1 peptides, in Europe, CordenPharma will construct a greenfield facility for small to large-scale peptide development and manufacturing.CDMO Touchlight signed a licensing agreement with GSK that grants the drug behemoth non-exclusive rights to use Touchlight’s proprietary enzymatic doggybone DNA (dbDNA) technology for the development and production of mRNA-based products, particularly vaccines. Curia also integrated enzymatic dbDNA solutions through a collaboration with Touchlight, enhancing mRNA production for vaccine and cancer therapies. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Lonza, Merck, Dr. Reddy’s owned Aurigene invest in cell and gene therapiesThe CGT space continued to draw both deals and investments. Lonza and Vertex signed a long-term commercial supply agreement for Casgevy, the world’s first CRISPR/Cas9 gene-edited cell therapy, to treat sickle cell disease and beta thalassemia. This agreement includes manufacturing at Lonza’s Geleen (the Netherlands) cell therapy manufacturing facility, with plans to expand to Portsmouth, New Hampshire (US).Miltenyi Biotec began manufacturing lentiviral vectors for Adaptimmune’s Tecelra, the first engineered TCR T-cell therapy for the rare soft tissue cancer synovial sarcoma approved by the US Food and Drug Administration.Merck KGaA commenced commercial production at its first GMP-compliant manufacturing line for cell culture media (CCM) in China. This facility addresses the growing local demand for quality custom CCM used in biopharmaceuticals, vaccines, and novel therapeutics.Aurigene and Edity Therapeutics announced a strategic collaboration in cell therapy, with Aurigene providing cell therapy discovery services to support Edity’s clinical development. Additionally, Aurigene and its parent, Dr. Reddy’s Laboratories, signed a memorandum of understanding (MoU) with Kainomyx for the development and commercialization of an affordable anti-malarial drug. ProBio and UCI Therapeutics signed an MoU for a comprehensive collaboration in gene delivery technologies, including viral and non-viral approaches. Additionally, Korea’s VaxCell-Bio partnered with ProBio to accelerate the development of its chimeric antigen receptor (CAR)-related therapies.The ADC market continued to be a hotbed of innovation and strategic expansion. Merck KGaA invested € 70 million (US$ 75 million) to triple its ADC manufacturing capacity at its Missouri (US) facility, aiming to support the rising demand for oncology therapies.Sterling Pharma entered into a partnership with GlycoNex to support the clinical trials of their ADCs that target solid tumors. And, NJ Bio and Charles River Laboratories also announced a collaboration to optimize ADC manufacturing.The adeno-associated viral (AAV) vector field also saw activity with Rentschler Biopharma and Forge Biologics announcing the launch of a new service offering and a manufacturing platform, respectively. Similarly, Andelyn Biosciences was selected by Hubble Therapeutics to manufacture clinical grade AAV.Meanwhile, Lonza has gone in for a restructuring exercise in order to become a “pure-play CDMO”. It has exited its capsules and health ingredients business, and adopted a new organizational structure. The Swiss CDMO has also extended a collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Our viewAs pharmaceutical development becomes increasingly complex, CDMOs are no longer just manufacturing partners, but critical innovation hubs. Little wonder then that 2024’s biggest pharma deal was in the CDMO space – Novo Holdings’ US$ 16.5 billion buyout of Catalent. This trend should gather momentum. We expect more M&A activity in this space in 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 400

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    #PharmaFlow by PHARMACOMPASS
    19 Dec 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Ipca Labs expects its US generics sales to touch $200 million soon
    Ipca Labs expects its US generics sales to touch $200 million soon

    21 Aug 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ipca-labs-expects-its-us-generics-sales-to-touch-200-million-soon/articleshow/112662992.cms

    ECONOMICTIMES
    21 Aug 2024
    Share Share
    Ipca Laboratories`s Generics Etodolac Receives Approval in US
    Ipca Laboratories`s Generics Etodolac Receives Approval in US

    01 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205448

    FDA
    01 Aug 2024
    Share Share
    Ipca Labs Generic Risperidone Receives Approval in US
    Ipca Labs Generic Risperidone Receives Approval in US

    26 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205104

    FDA
    26 Jun 2024
    Share Share
    Ipca Labs's Generic Alendronate Sodium Receives Approval in US
    Ipca Labs's Generic Alendronate Sodium Receives Approval in US

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206387

    FDA
    04 Jun 2024
    Share Share
    Ipca Labs Generic Levocetirizine Dihydrochloride Receives Approval in The US
    Ipca Labs Generic Levocetirizine Dihydrochloride Receives Approval in The US

    06 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204626

    FDA
    06 May 2024
    Share Share
    Ipca Lab's Generic Etodolac Receives Approval in the U.S.
    Ipca Lab's Generic Etodolac Receives Approval in the U.S.

    01 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204729

    FDA
    01 May 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Alendronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Alendronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-11-14

    Pay. Date : 2013-07-30

    DMF Number : 21008

    Submission : 2007-12-03

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-090 - Rev 02

    Issue Date : 2021-04-27

    Type : Chemical

    Substance Number : 1564

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10310

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

    Initial Date of Registration : 2007-10-05

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1157

    Start Marketing Date : 2013-08-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Furosemide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Furosemide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-23

    Pay. Date : 2013-07-15

    DMF Number : 10109

    Submission : 1993-02-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-020 - Rev 07

    Issue Date : 2019-10-30

    Type : Chemical

    Substance Number : 391

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10191

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2013-10-09

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-0006

    Start Marketing Date : 2012-02-28

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Glimepiride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Glimepiride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-02-20

    Pay. Date : 2013-11-06

    DMF Number : 20037

    Submission : 2006-12-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-036 - Rev 01

    Issue Date : 2019-12-18

    Type : Chemical

    Substance Number : 2223

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10075

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2014-04-02

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1151

    Start Marketing Date : 2012-02-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sungwoo Chemical Co., Ltd.

    Registration Date : 2013-10-20

    Registration Number : 20080627-78-D-31-14(5)

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : PO Sejavta, District-Ratlam (MP) 457001, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Hydrochlorothiazide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Hydrochlorothiazide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-11

    Pay. Date : 2012-12-05

    DMF Number : 16707

    Submission : 2003-07-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-013 - Rev 06

    Issue Date : 2023-08-29

    Type : Chemical

    Substance Number : 394

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 224MF10171

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2012-08-16

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1127

    Start Marketing Date : 2012-03-02

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Aging Life Science Co., Ltd.

    Registration Date : 2021-03-10

    Registration Number : 20210310-209-J-862

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : Sejavta Dist. Ratlam(MP)PIN. 457 002 India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Metoprolol Tartrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Metoprolol Tartrate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15850

    Submission : 2002-02-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-091 - Rev 04

    Issue Date : 2023-03-16

    Type : Chemical

    Substance Number : 1028

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10151

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, INDIA

    Initial Date of Registration : 2009-07-09

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1163

    Start Marketing Date : 2019-11-08

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Propranolol Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Propranolol Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-31

    Pay. Date : 2013-07-23

    DMF Number : 15849

    Submission : 2002-02-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2002-026 - Rev 06

    Issue Date : 2023-12-06

    Type : Chemical

    Substance Number : 568

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10174

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2006-02-08

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1124

    Start Marketing Date : 2012-03-29

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Atenolol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Atenolol

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7821

    Submission : 1988-12-15

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1998-024 - Rev 06

    Issue Date : 2023-11-10

    Type : Chemical

    Substance Number : 703

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10439

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2006-04-27

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1115

    Start Marketing Date : 2012-02-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Shinil Pharmaceutical Co., Ltd.

    Registration Date : 2012-10-11

    Registration Number : 20050831-34-B-91-04(12)

    Manufacturer Name : Ipca Laboratories Limited.

    Manufacturer Address : PO Sejavta Dist. Ratlam(MP)PIN. 457 002, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Losartan Potassium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Losartan Potassium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16526

    Submission : 2003-04-05

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2019-224 - Rev 03

    Issue Date : 2023-01-12

    Type : Chemical

    Substance Number : 2232

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10266

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2010-12-08

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Ildong Pharmaceutical Co., Ltd.

    Registration Date : 2020-06-29

    Registration Number : 20100226-122-G-47-16(6)

    Manufacturer Name : IPCA Laboratories Limited@Ipca Laboratories Limited@[Manufacturer of intermediate (Losartan base)] Ipca Laboratories Limited, Mahad

    Manufacturer Address : PO Sejavta, District Ratlam (MP), India@Block No. 123, 131 & 132, Village-Ranu, Tal-Padra, City : Ranu, Dist : Vadodara, Gujarat state, India@[Manufacturer of intermediate (Losartan base)] C-89 to C-95, MIDC Industrial Area, Mahad Dist. Raigad (MS)-402309 (Maharashtra), India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Chlorthalidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Chlorthalidone

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-23

    Pay. Date : 2013-07-15

    DMF Number : 17808

    Submission : 2004-11-03

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-004 - Rev 00

    Issue Date : 2013-04-19

    Type : Chemical

    Substance Number : 546

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1134

    Start Marketing Date : 2013-10-26

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Daehan New Pharm Co., Ltd.

    Registration Date : 2024-02-23

    Registration Number : 20180406-209-J-47(6)

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : PO Sejavta Dist. Ratlam(MP)-457 001, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Hydroxychloroquine Sulphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Hydroxychloroquine Sulphate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-31

    Pay. Date : 2013-07-17

    DMF Number : 14087

    Submission : 1999-04-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-196 - Rev 02

    Issue Date : 2023-10-24

    Type : Chemical

    Substance Number : 2849

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-0198

    Start Marketing Date : 2012-02-24

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hwail Pharmaceutical Co., Ltd.

    Registration Date : 2022-05-31

    Registration Number : 20201207-209-J-796(2)

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : PO Sejavta, District-Ratlam (MP) 457001, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Allopurinol

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    02

    Amlodipine besilate

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    03

    Amlodipine besilate, AK4 process

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    04

    Atenolol

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    05

    Atovaquone

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    06

    Bendroflumethiazide

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    07

    Bisoprolol fumarate

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    08

    Carvedilol

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    09

    Celecoxib

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow

    10

    Cetirizine dihydrochloride

    CEP/COS

    Antibody Engineering
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ipca Laboratories and get a quotation

    Ipca Laboratories is a supplier offers 151 products (APIs, Excipients or Intermediates).

    Find a price of Alendronate Sodium bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Furosemide bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Glimepiride bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Metoprolol Tartrate bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Propranolol Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Atenolol bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Allopurinol bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Amlodipine Besylate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Carvedilol bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Chloroquine Phosphate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Chlorthalidone bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Famotidine bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Hydroxychloroquine Sulphate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Hydroxyzine Dihydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Indapamide bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Metformin bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Metoclopramide Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Nifedipine bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Primaquine Diphosphate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Proguanil bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Pyrantel Pamoate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Pyrimethamine bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Quetiapine Hemifumarate bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Telmisartan bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Torsemide bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Trimethoprim bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Warfarin Sodium bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Bendroflumethiazide bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Bisoprolol Fumarate bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Citalopram Hydrobromide bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Etodolac bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Fenofibrate bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Fluconazole bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Flumequine bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Mesalazine bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Methylphenidate Hydrochloride bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Metoprolol Succinate bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Nabumetone bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Paroxetine Hydrochloride bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Valsartan bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Atovaquone bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Chlorthalidone bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Lamotrigine bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Mesalazine bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Metoclopramide bulk with JDMF, WC offered by Ipca Laboratories

    Find a price of Midodrine bulk with DMF, WC offered by Ipca Laboratories

    Find a price of Olanzapine bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Ondansetron bulk with DMF, WC offered by Ipca Laboratories

    Find a price of Promethazine Hydrochloride bulk with DMF, WC offered by Ipca Laboratories

    Find a price of Risperidone bulk with DMF, WC offered by Ipca Laboratories

    Find a price of Tramadol Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Triamterene bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Amodiaquine Hydrochloride bulk with WC offered by Ipca Laboratories

    Find a price of Artemether bulk with WC offered by Ipca Laboratories

    Find a price of Artesunate bulk with WC offered by Ipca Laboratories

    Find a price of Atenolol bulk with DMF offered by Ipca Laboratories

    Find a price of Benzarone bulk with JDMF offered by Ipca Laboratories

    Find a price of Benzbromarone bulk with JDMF offered by Ipca Laboratories

    Find a price of Cilostazol bulk with WC offered by Ipca Laboratories

    Find a price of Clopidogrel bulk with WC offered by Ipca Laboratories

    Find a price of Famotidine bulk with CEP offered by Ipca Laboratories

    Find a price of Lumefantrine bulk with WC offered by Ipca Laboratories

    Find a price of Metformin bulk with DMF offered by Ipca Laboratories

    Find a price of Risedronate Sodium bulk with WC offered by Ipca Laboratories

    Find a price of Sulfadoxine bulk with WC offered by Ipca Laboratories

    Find a price of Warfarin Sodium bulk with CEP offered by Ipca Laboratories

    Find a price of Zaltoprofen bulk with JDMF offered by Ipca Laboratories

    Find a price of Zoledronic Acid bulk with JDMF offered by Ipca Laboratories

    Find a price of Amlodipine Besylate bulk with CEP offered by Ipca Laboratories

    Find a price of Amylmetacresol bulk with WC offered by Ipca Laboratories

    Find a price of Bisoprolol Fumarate bulk with DMF offered by Ipca Laboratories

    Find a price of Bupropion Hydrochloride bulk with DMF offered by Ipca Laboratories

    Find a price of Celecoxib bulk with CEP offered by Ipca Laboratories

    Find a price of Cetirizine Dihydrochloride bulk with DMF offered by Ipca Laboratories

    Find a price of Dichlorobenzyl Alcohol bulk with WC offered by Ipca Laboratories

    Find a price of Donepezil bulk with CEP offered by Ipca Laboratories

    Find a price of Entacapone bulk with CEP offered by Ipca Laboratories

    Find a price of Etodolac bulk with DMF offered by Ipca Laboratories

    Find a price of Furosemide bulk with JDMF offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with CEP offered by Ipca Laboratories

    Find a price of Isotretinoin bulk offered by Ipca Laboratories

    Find a price of Levetiracetam bulk with CEP offered by Ipca Laboratories

    Find a price of Levofloxacin bulk with WC offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk offered by Ipca Laboratories

    Find a price of Meloxicam bulk with CEP offered by Ipca Laboratories

    Find a price of Metoprolol Succinate bulk with DMF offered by Ipca Laboratories

    Find a price of Metoprolol Tartrate bulk with DMF offered by Ipca Laboratories

    Find a price of Morantel Tartrate bulk with WC offered by Ipca Laboratories

    Find a price of Pantoprazole Sodium bulk offered by Ipca Laboratories

    Find a price of Pentoxifylline bulk offered by Ipca Laboratories

    Find a price of Perindopril Erbumine bulk offered by Ipca Laboratories

    Find a price of Probenecid bulk with DMF offered by Ipca Laboratories

    Find a price of Quetiapine Hemifumarate bulk with CEP offered by Ipca Laboratories

    Find a price of Ractopamine Hydrochloride bulk with WC offered by Ipca Laboratories

    Find a price of Risedronate Sodium bulk with DMF offered by Ipca Laboratories

    Find a price of Tramadol Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Trazodone Hydrochloride bulk with CEP offered by Ipca Laboratories

    Find a price of Triclabendazole bulk with WC offered by Ipca Laboratories

    Find a price of Trimethoprim bulk with DMF offered by Ipca Laboratories

    Find a price of Valsartan bulk with DMF offered by Ipca Laboratories

    Find a price of Zopiclone bulk with WC offered by Ipca Laboratories

    Find a price of DULOXETINE HYDROCHLORIDE USP bulk with DMF offered by Ipca Laboratories

    Find a price of Alendronate Sodium bulk offered by Ipca Laboratories

    Find a price of Allopurinol bulk offered by Ipca Laboratories

    Find a price of Balsalazide Disodium bulk offered by Ipca Laboratories

    Find a price of Clopidogrel bulk offered by Ipca Laboratories

    Find a price of Erythromycin Estolate bulk offered by Ipca Laboratories

    Find a price of Escitalopram Oxalate bulk offered by Ipca Laboratories

    Find a price of Estradiol Valerate bulk offered by Ipca Laboratories

    Find a price of Fluconazole bulk offered by Ipca Laboratories

    Find a price of Flumequine bulk offered by Ipca Laboratories

    Find a price of Lisinopril bulk offered by Ipca Laboratories

    Find a price of Mesalazine bulk offered by Ipca Laboratories

    Find a price of Nabumetone bulk offered by Ipca Laboratories

    Find a price of Nifedipine bulk offered by Ipca Laboratories

    Find a price of Norethisterone bulk offered by Ipca Laboratories

    Find a price of Norethisterone Acetate bulk offered by Ipca Laboratories

    Find a price of Pyrantel Pamoate bulk offered by Ipca Laboratories

    Find a price of Pyrantel Tartrate bulk offered by Ipca Laboratories

    Find a price of Ritalinic Acid bulk offered by Ipca Laboratories

    Find a price of Testosterone bulk offered by Ipca Laboratories

    Find a price of Testosterone Propionate bulk offered by Ipca Laboratories

    Find a price of Testosterone Undecanoate bulk offered by Ipca Laboratories

    Find a price of Tibolone bulk offered by Ipca Laboratories

    Find a price of Triclosan bulk offered by Ipca Laboratories

    Find a price of Zolpidem Tartrate bulk offered by Ipca Laboratories

    Find a price of IBD-IV MANUFACTURING FACILITY IN RATLAM, INDIA bulk offered by Ipca Laboratories

    Find a price of FACILITY FOR BULK DRUG PRODUCTION IN INDORE INDIA bulk offered by Ipca Laboratories

    Find a price of FACILITY IBD-D IN PIN., INDIA bulk offered by Ipca Laboratories

    Find a price of Arteether bulk offered by Ipca Laboratories

    Find a price of Cetirizine bulk offered by Ipca Laboratories

    Find a price of Citalopram bulk offered by Ipca Laboratories

    Find a price of Estradiol bulk offered by Ipca Laboratories

    Find a price of Nandrolone Phenpropionate bulk offered by Ipca Laboratories

    Find a price of Phenylephrine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Piperaquine Phosphate bulk offered by Ipca Laboratories

    Find a price of Serratiopeptidase bulk offered by Ipca Laboratories

    Find a price of Silodosin bulk offered by Ipca Laboratories

    Find a price of Simvastatin bulk offered by Ipca Laboratories

    Find a price of Sumatriptan bulk offered by Ipca Laboratories

    Find a price of Testosterone Cypionate bulk offered by Ipca Laboratories

    Find a price of Testosterone Decanoate bulk offered by Ipca Laboratories

    Find a price of Testosterone Isocaproate bulk offered by Ipca Laboratories

    Find a price of Testosterone Phenylpropionate bulk offered by Ipca Laboratories

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search